Somnath Sarkar

5.7k total citations · 1 hit paper
75 papers, 4.3k citations indexed

About

Somnath Sarkar is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, Somnath Sarkar has authored 75 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Orthopedics and Sports Medicine and 16 papers in Molecular Biology. Recurrent topics in Somnath Sarkar's work include Bone health and osteoporosis research (19 papers), Bone Metabolism and Diseases (15 papers) and Colorectal Cancer Treatments and Studies (14 papers). Somnath Sarkar is often cited by papers focused on Bone health and osteoporosis research (19 papers), Bone Metabolism and Diseases (15 papers) and Colorectal Cancer Treatments and Studies (14 papers). Somnath Sarkar collaborates with scholars based in United States, India and France. Somnath Sarkar's co-authors include Herbert I. Hurwitz, Fairooz F. Kabbinavar, Kristine D. Harper, Dennis M. Black, R. Mass, Bruce Mitlak, Pierre D. Delmas, Julie Hambleton, Emily K. Bergsland and Mayme Wong and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Somnath Sarkar

73 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

2005 522 citations Fairooz F. Kabbinavar, Herbert I. Hurwitz et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Somnath Sarkar

Since Specialization

Citations

This map shows the geographic impact of Somnath Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Somnath Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Somnath Sarkar more than expected).

Fields of papers citing papers by Somnath Sarkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Somnath Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Somnath Sarkar. The network helps show where Somnath Sarkar may publish in the future.

Co-authorship network of co-authors of Somnath Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Somnath Sarkar. A scholar is included among the top collaborators of Somnath Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Somnath Sarkar. Somnath Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023 2024 ·JNCI Cancer Spectrum ·Jenny S. Guadamuz, Xiaoliang Wang, Ivy Altomare, (unknown), Somnath Sarkar, Ronac Mamtani, Gregory S. Calip	0
2	HPR128 Benchmarking Clinical Trial Diversity: Methods to Characterize Eligibility-Based Representativeness 2024 ·Value in Health ·Corey M. Benedum, (unknown), Selen Bozkurt, Somnath Sarkar	1
3	Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations 2022 ·Contemporary Clinical Trials Communications ·(unknown), (unknown), Melissa D. Curtis, Shrujal S. Baxi, William B. Capra, Elizabeth Garrett‐Mayer, Brian P. Hobbs, David S. Hong, Rebecca A. Hubbard, Jiawen Zhu, Somnath Sarkar, Meghna Samant	10
4	An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma 2019 ·Contemporary Clinical Trials ·(unknown), Jiawen Zhu, Federico Mattiello, Somnath Sarkar, (unknown)	17
5	Dermatofibroma: Atypical presentations 2016 ·Indian Journal of Dermatology ·(unknown), (unknown), (unknown), Somnath Sarkar	7
6	Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials 2008 ·Journal of Clinical Oncology ·Fairooz F. Kabbinavar, Herbert I. Hurwitz, Jing Yi, Somnath Sarkar, Oliver Rosen	135
7	Place-Based Investigations and Authentic Inquiry: Hands-On Activities Are Elevated to a Meaningful Level That Fosters Student Engagement and Purposeful Learning 2008 ·The Science Teacher ·Somnath Sarkar, (unknown)	2
8	Place-Based Investigations and Authentic Inquiry. 2008 ·The Science Teacher ·Somnath Sarkar, (unknown)	21
9	Quantifying the treatment effect explained by markers in the presence of measurement error 2006 ·Statistics in Medicine ·Somnath Sarkar, Yongming Qu	7
10	Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial 2005 ·American Journal of Psychiatry ·Kristine Yaffe, Kathryn A. Krueger, Steven R. Cummings, Terri Blackwell, Victor W. Henderson, Somnath Sarkar, Kristine E. Ensrud, Deborah Grady	150
11	Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab 2005 ·Journal of Surgical Oncology ·Frank A. Scappaticci, Louis Fehrenbacher, Thomas H. Cartwright, John D. Hainsworth, W. Heim, Jordan Berlin, Fairooz F. Kabbinavar, William Novotny, Somnath Sarkar, Herbert I. Hurwitz	396
12	Safety and Adverse Effects Associated With Raloxifene: Multiple Outcomes of Raloxifene Evaluation 2004 ·Obstetrics and Gynecology ·Deborah Grady, Bruce Ettinger, E Moscarelli, Leo Plouffe, Somnath Sarkar, A Ciaccia, Steven R. Cummings	116
13	Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk 2003 ·Bone ·Jean‐Yves Reginster, Somnath Sarkar, Brigitte Zegels, Yves Henrotin, Olivier Bruyère, D. Agnusdei, J. Collette	80
14	Contribution of Raloxifene and Calcium and Vitamin D₃Supplementation to the Increase of the Degree of Mineralization of Bone in Postmenopausal Women 2003 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Paul Lips, Susan M. Ott, Kristine D. Harper, Somnath Sarkar, (unknown), Pierre J. Meunier	71
15	Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Pierre D. Delmas, Kristine E. Ensrud, Jonathan D. Adachi, Kristine D. Harper, Somnath Sarkar, C. Gennari, Jean‐Yves Reginster, Huibert A. P. Pols, Robert R. Recker, Steven T. Harris, Wentao Wu, Harry K. Genant, Dennis M. Black, Richard Eastell	438
16	Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis 2002 ·Archives of Internal Medicine ·Michael Maricic, Jonathan D. Adachi, Somnath Sarkar, Wentao Wu, Mayme Wong, Kristine D. Harper	119
17	Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with ostoporosis : 4-year results from the MORE trial 2001 ·Open Repository and Bibliography (University of Liège) ·H.A.P. Pols, Richard Eastell, Pierre Delmas, Jonathan D. Adachi, Kristine E. Ensrud, Kristine D. Harper, Somnath Sarkar, C. Gennari, Jean‐Yves Reginster, Robert R. Recker, Steven A. Harris, Wei Wu, (unknown), H K Genant	2
18	Cognitive Function in Postmenopausal Women Treated with Raloxifene 2001 ·New England Journal of Medicine ·Kristine Yaffe, (unknown), Somnath Sarkar, (unknown), Elizabeth Barrett‐Connor, David A. Cox, Thomas Nickélsen	159
19	The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial 2000 ·Open Repository and Bibliography (University of Liège) ·Richard Eastell, Jonathan D. Adachi, Kristine D. Harper, Somnath Sarkar, PD Delmas, Kristine E. Ensrud, C. Gennari, Jean‐Yves Reginster, H. A. P. Pols, Robert R. Recker, Steven T. Harris, Wei Wu, H K Genant, D Black	6
20	Effects of raloxifene on bone mineral density and biochemical markers of bone turnover in postmenopausal women with osteoporosis : 4-year results from the MORE trial 2000 ·Open Repository and Bibliography (University of Liège) ·PD Delmas, (unknown), Kristine D. Harper, Wen‐Lan Wu, Jonathan D. Adachi, Richard Eastell, C. Gennari, Jean‐Yves Reginster, H.A.P. Pols, Robert R. Recker, N. H. Bjarnason, Somnath Sarkar, D Black, H K Genant	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact